Equine/Horse infectious anemia Virus P26 antibody and antigen (recombinant protein)
Diagnostic anti-Equine/Horse infectious anemia Virus P26 antibodies pairs and antigen for animal health (animal Equine/Horse infectious disease Equine/Horse infectious anemia) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine/Horse disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-VT-P139-Tg002-Ag01 | Recombinant Equine/Horse infectious anemia Virus P26 protein | $3090.00 |
GMP-VT-P139-Tg002-Ab01 | Anti-Equine/Horse infectious anemia Virus P26 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P139-Tg002-Ab02 | Anti-Equine/Horse infectious anemia Virus P26 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P139-Tg002-Ab03 | Anti-Equine/Horse infectious anemia Virus P26 human monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P139-Tg002-Ab04 | Anti-Equine/Horse infectious anemia Virus P26 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-VT-P139-Tg002-Ag01 |
Product Name | Recombinant Equine/Horse infectious anemia Virus P26 protein |
Pathogen | Equine/Horse infectious anemia Virus |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine/Horse infectious anemia Virus P26 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Equine/Horse infectious anemia Virus level test of animal Equine/Horse infectious disease with Equine/Horse infectious anemia. |
Tag | His | Product description | Recombinant Equine/Horse infectious anemia Virus P26 proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P139-Tg002-Ab01,GMP-VT-P139-Tg002-Ab02 |
Pathogen | Equine/Horse infectious anemia Virus |
Product Name | Anti-Equine/Horse infectious anemia Virus P26 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine/Horse infectious anemia Virus P26 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine/Horse infectious anemia Virus antibodies in Equine/Horse infectious anemia Virus level test of animal Equine/Horse infectious disease with Equine/Horse infectious anemia. |
Product description | Anti-Equine/Horse infectious anemia Virus P26 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine/Horse infectious anemia Virus antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P139-Tg002-Ab03,GMP-VT-P139-Tg002-Ab04 |
Pathogen | Equine/Horse infectious anemia Virus |
Product Name | Anti-Equine/Horse infectious anemia Virus P26 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine/Horse infectious anemia Virus P26 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine/Horse infectious anemia Virus antibodies in Equine/Horse infectious anemia Virus level test of animal Equine/Horse infectious disease with Equine/Horse infectious anemia. |
Product description | Anti-Equine/Horse infectious anemia Virus P26 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Pathogen Information
Equine infectious anemia virus (EIAV), also known as horse infectious anemia virus, is a retrovirus that causes equine infectious anemia (EIA) in horses, mules, and donkeys. The virus is primarily transmitted through blood-to-blood contact, such as from biting insects or contaminated needles. While some horses may show no symptoms, they can still serve as carriers of the virus and spread it to other horses.
EIAV is classified as a type of RNA virus called a retrovirus. Retroviruses use reverse transcriptase to produce DNA from its RNA genome for replication within host cells. The main gene responsible for EIAV's structure and function is the env gene, which codes for envelope glycoproteins crucial for viral entry into host cells. Among these glycoproteins, glycoprotein 90 (gp90) plays a crucial role in mediating attachment and entry into host cells.
When horses are infected with EIAV, they may develop acute or chronic illness. Symptoms of EIA include lethargy, weight loss, fever, swelling, and anemia. Infected horses may also experience depression, jaundice, and hemorrhaging. However, some infected horses may not show any symptoms at all.
Diagnosing EIAV requires specialized testing using serological methods or Polymerase Chain Reaction (PCR). In the serological testing method, the agar gel immunodiffusion (AGID) test is used to detect antibodies against the virus present in blood samples. This test is based on the principle of antigen-antibody reactions where antibodies present in the sample react with specific antigens to form visible bands. However, this test does not detect the virus directly, but rather the antibodies produced by the horse in response to the virus.
PCR testing is another method used to detect EIAV. PCR is a highly sensitive molecular biology technique used to amplify and detect specific DNA or RNA sequences. This test can directly detect viral RNA or DNA in blood samples by targeting viral env genes or their corresponding proteins. PCR testing is considered more sensitive and specific than the AGID test, but requires specialized laboratory equipment and trained personnel.
There is currently no vaccine available for EIAV, and treatment options are limited. Infected horses may require supportive care and management to minimize symptoms. However, due to the highly contagious nature of the virus, infected horses are typically euthanized to prevent transmission to other horses.
In conclusion, EIAV is a serious viral infection that affects horses, mules, and donkeys. It can cause acute or chronic illness with a range of symptoms and can be transmitted through blood-to-blood contact. Diagnosis of EIAV requires specialized testing using serological methods or PCR. While there is no vaccine available for EIAV, prevention measures such as proper management practices and regular screening can help reduce the spread of the virus within horse populations.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.